Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Samsung Biologics announced a new agreement with Bristol Myers Squibb for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic relationship over time. Under the terms of the new agreement, […]

Pistoia Alliance Enables Instant, Secure Transfer of Analytical Methods and Results Data Ahead of FDA Guidance

The Pistoia Alliance has announced an industry first for its Methods Hub project; the cloud-based collaborative tool now enables the instant transfer and overlaying of analytical methods and results data in a single platform and between different instrument hardware and software vendors. The proof of concept has been successfully implemented at GSK and will now […]

Automation Technology Reshaping The Prefilled Syringe Sector

Over the last two decades, technology has greatly expanded our capabilities and, consequently, raised expectations for manufacturers. These evolving capabilities have often aligned with, or perhaps even influenced, significant growth in certain pharmaceutical segments. One such niche is prefilled syringes, which have seen a remarkable surge in popularity in recent years. Without new automation-enabling technologies, […]

Biologics Fuel Demand For Aseptic Fill-Finish Manufacturing

Projected data suggests that the global expenditure on medications will reach $1.29 trillion by 2027 i . This surge in spending has led to a heightened demand for contract manufacturing organizations (CMOs) to undertake aseptic fill-finish manufacturing agreements, particularly for parenteral products. Executing the production of pharmaceuticals under tightly controlled environmental conditions serves the dual […]

Pistoia Alliance Launches Lab of the Future Report, Finding AI is Set to be Top Technology Investment for Life Sciences Companies Over Next Two Years

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is releasing the results of a new global survey conducted in partnership with Open Pharma Research, organizers of the Lab of the Future Congress, examining lab technology investment, barriers, and benefits. The Alliance surveyed 200 experts spanning Europe, the […]

DoKaSch Temperature Solutions expands its business in India

The Indian pharmaceutical industry worldwide ranks third in pharmaceutical production by volume, according to the Indian government. In order to position itself even better in this region, DoKaSch Temperature Solutions has announced James Savio as Business Development Manager India. “I want to expand the market presence of DoKaSch Temperature Solutions across the Pharmaceuticals main markets in […]

Sever Pharma Solutions breaks ground with new high potency drug manufacturing suites

Sever Pharma Solutions, a leading pharmaceutical contract development and manufacturing organization (CDMO), has announced the groundbreaking of its new high potency active pharmaceutical ingredients (HPAPI) manufacturing suites. The company’s investment in these new state-of-the-art manufacturing facilities will allow them to better serve pharmaceutical clients seeking the rare combination of HPAPI Drug Product development, clinical and […]

Bora merges with Sunway Biotech to launch global Nutraceuticals offering

Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its merged with Sunway Biotech, a leading ingredients manufacturer, and research and development (R&D) organization. Resulting in the parent company of Bora Health, Bora Pharmaceuticals becoming the largest shareholder of Sunway Biotech. Sunway […]

Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth

Mural Health Technologies, Inc. a next-generation clinical trial participant management platform announced that it has raised $8 million in seed funding, led by Bessemer Venture Partners, with participation from Virtue VC, Operator Partners, Arkitect Ventures, Correlation Ventures, and Project Mayhem Ventures. The investment empowers the company to accelerate the growth of its Mural Link platform […]

As Lonza CEO departs, Catalent scoops up rival CDMO’s bioscience business head to lead biologics

Mere hours after it surfaced that Lonza’s CEO, Pierre-Alain Ruffieux, will step down, the Swiss CDMO has lost another major executive. And this time, the exec is jumping ship to U.S. contract manufacturing rival Catalent. Monday, Catalent named Lonza’s David McErlane group president of its biologics segment. McErlane, who most recently served as Lonza’s senior […]